ロード中...
Advances in autoimmune myasthenia gravis management
INTRODUCTION. Myasthenia gravis (MG) is an autoimmune neuromuscular disorder with no cure and conventional treatments limited by significant adverse effects and variable benefit. In the last decade, therapeutic development has expanded based on improved understanding of autoimmunity and financial in...
保存先:
| 出版年: | Expert Rev Neurother |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6289049/ https://ncbi.nlm.nih.gov/pubmed/29932785 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14737175.2018.1491310 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|